Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010

Serum Albumin Levels and Cancer Survival

Sample size: 59 publication 10 minutes Evidence: high

Author Information

Author(s): Gupta Digant, Lis Christopher G

Primary Institution: Cancer Treatment Centers of America® at Midwestern Regional Medical Center, Zion, IL, USA

Hypothesis

Does pretreatment serum albumin level predict cancer survival?

Conclusion

Higher pretreatment serum albumin levels are associated with better survival outcomes in cancer patients.

Supporting Evidence

  • 29 studies on gastrointestinal cancers showed higher serum albumin levels associated with better survival.
  • 10 studies on lung cancer found similar associations.
  • 6 studies on female cancers indicated lower serum albumin levels linked to poor survival.
  • 8 studies on other cancer sites also showed lower serum albumin associated with poor survival.

Takeaway

If you have higher levels of a protein called albumin in your blood before cancer treatment, you might live longer.

Methodology

A systematic review of epidemiological studies from MEDLINE on serum albumin and cancer survival.

Potential Biases

Potential publication bias exists as studies with positive results are more likely to be published.

Limitations

The review may be subject to publication bias and only includes studies published in English.

Participant Demographics

Studies included various cancer types and did not restrict by age, ethnicity, or cancer stage.

Digital Object Identifier (DOI)

10.1186/1475-2891-9-69

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication